BIOMARK DIAGNOSTICS INC./ CA09073K1084 /
| 2024-04-19 8:10:51 AM | Chg. +0.0060 | Volume | Bid3:30:01 PM | Ask3:30:01 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.1730EUR | +3.59% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 0.1730 | 0.1730 |
Newsfile Corp
2023-06-05
BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASC...
Newsfile Corp
2023-01-11
BioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It ...
Newsfile Corp
2021-11-30
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project t...
Newsfile Corp
2021-11-30
BioMark participera avec Astrazeneca, Pfizer Canada et la Fondation de l'IUCPQ à un projet de 3,5 m$...
Newsfile Corp
2021-11-16
BioMark obtiens un financement pour accélérer le développement de sa technologie de biopsie liquide ...
Newsfile Corp
2021-10-18
Liquid Biopsy Company BioMark to Present at the 3rd Annual Congress of the International Society of ...
Newsfile Corp
2021-06-29
Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy
Newsfile Corp
2021-06-01
BioMark reçoit une subvention de 825 000 $ pour développer son test de biopsie liquide pour le dépis...
